NO990594L - Farmas°ytisk aerosolsammensetning - Google Patents

Farmas°ytisk aerosolsammensetning

Info

Publication number
NO990594L
NO990594L NO990594A NO990594A NO990594L NO 990594 L NO990594 L NO 990594L NO 990594 A NO990594 A NO 990594A NO 990594 A NO990594 A NO 990594A NO 990594 L NO990594 L NO 990594L
Authority
NO
Norway
Prior art keywords
aerosol composition
surface aerosol
pharmaceutical surface
pharmaceutical
composition
Prior art date
Application number
NO990594A
Other languages
English (en)
Other versions
NO327775B1 (no
NO990594D0 (no
Inventor
David Lewis
David Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO990594(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO990594D0 publication Critical patent/NO990594D0/no
Publication of NO990594L publication Critical patent/NO990594L/no
Publication of NO327775B1 publication Critical patent/NO327775B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19990594A 1997-06-13 1999-02-09 Farmasoytisk aerosolsammensetning NO327775B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (3)

Publication Number Publication Date
NO990594D0 NO990594D0 (no) 1999-02-09
NO990594L true NO990594L (no) 1999-04-13
NO327775B1 NO327775B1 (no) 2009-09-21

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990594A NO327775B1 (no) 1997-06-13 1999-02-09 Farmasoytisk aerosolsammensetning

Country Status (45)

Country Link
EP (2) EP0920302B2 (no)
JP (1) JP4380802B2 (no)
KR (1) KR100546239B1 (no)
CN (1) CN1138532C (no)
AR (1) AR012977A1 (no)
AT (1) ATE222751T1 (no)
AU (1) AU729966B2 (no)
BG (1) BG63906B1 (no)
BR (1) BR9805993B1 (no)
CA (1) CA2263445C (no)
CO (1) CO4940408A1 (no)
CZ (1) CZ295521B6 (no)
DE (1) DE69807420T3 (no)
DK (1) DK0920302T4 (no)
DZ (1) DZ2516A1 (no)
EA (1) EA001259B1 (no)
EE (1) EE03664B1 (no)
ES (1) ES2182351T5 (no)
GB (1) GB2326334A (no)
GE (1) GEP20012462B (no)
HK (1) HK1022271A1 (no)
HR (1) HRP980317B1 (no)
HU (1) HU228487B1 (no)
ID (1) ID21491A (no)
IL (1) IL128484A (no)
IN (1) IN189317B (no)
IS (1) IS2435B (no)
IT (1) IT1293803B1 (no)
MA (1) MA26507A1 (no)
ME (2) MEP44008A (no)
MY (1) MY119074A (no)
NO (1) NO327775B1 (no)
NZ (1) NZ334149A (no)
PL (1) PL193721B1 (no)
PT (1) PT920302E (no)
RS (1) RS51274B (no)
SA (1) SA98190821B1 (no)
SI (1) SI0920302T2 (no)
SK (1) SK284430B6 (no)
TN (1) TNSN98087A1 (no)
TR (1) TR199900288T1 (no)
TW (1) TW555570B (no)
UA (1) UA70289C2 (no)
WO (1) WO1998056349A1 (no)
ZA (1) ZA985136B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317904B1 (it) 1999-09-11 2003-07-15 Glaxo Group Ltd Formulazione farmaceutica di propionato di fluticasone.
ATE286716T1 (de) * 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
PT1273292E (pt) 2001-07-02 2004-10-29 Chiesi Farma Spa Formulacao optimizada de tobramicina para aerossolizacao
MXPA04008372A (es) 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
PT1608336E (pt) * 2003-03-20 2008-04-21 Boehringer Ingelheim Pharma Formulação para aerossol doseador utilizando hidro-fluroalcanos como propulsores
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
JP2011503058A (ja) * 2007-11-07 2011-01-27 アストラゼネカ・アクチエボラーグ アスコルビン酸誘導体含有乾燥粉末製剤
WO2012032010A1 (en) * 2010-09-06 2012-03-15 Chiesi Farmaceutici S.P.A. Metered-dose inhaler and method of using the same
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
AU2017328908B2 (en) * 2016-09-19 2020-04-02 Mexichem Fluor S.A. De C.V. Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240484B1 (de) † 1986-03-10 1992-01-15 Kurt Dr. Burghart Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben
DE3767615D1 (de) † 1986-03-10 1991-02-28 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2769925B2 (ja) † 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE203902T1 (de) † 1991-06-10 2001-08-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
WO1992022287A1 (en) † 1991-06-10 1992-12-23 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
RO117414B1 (ro) * 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
AU700162B2 (en) † 1994-05-13 1998-12-24 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
IES970858A2 (en) † 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
DE59804534D1 (de) † 1997-02-05 2002-07-25 Jago Res Ag Muttenz Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
ZA985136B (en) 1999-01-07
TR199900288T1 (xx) 1999-09-21
PT920302E (pt) 2002-11-29
MA26507A1 (fr) 2004-12-20
HUP0001339A2 (hu) 2000-09-28
EP0920302B1 (en) 2002-08-28
IN189317B (no) 2003-02-08
BR9805993A (pt) 1999-08-31
TW555570B (en) 2003-10-01
HK1022271A1 (en) 2000-08-04
SI0920302T2 (sl) 2006-10-31
RS51274B (sr) 2010-12-31
CA2263445C (en) 2008-09-09
CZ295521B6 (cs) 2005-08-17
KR100546239B1 (ko) 2006-01-26
HUP0001339A3 (en) 2000-10-30
IL128484A0 (en) 2000-01-31
HU228487B1 (en) 2013-03-28
WO1998056349A1 (en) 1998-12-17
ID21491A (id) 1999-06-17
NO327775B1 (no) 2009-09-21
EP0920302A1 (en) 1999-06-09
EP0920302B2 (en) 2006-06-21
BG103221A (en) 1999-09-30
TNSN98087A1 (fr) 2005-03-15
JP4380802B2 (ja) 2009-12-09
MY119074A (en) 2005-03-31
EE03664B1 (et) 2002-04-15
SA98190821B1 (ar) 2006-11-19
KR20000068171A (ko) 2000-11-25
EA001259B1 (ru) 2000-12-25
CA2263445A1 (en) 1998-12-17
GB2326334A (en) 1998-12-23
SI0920302T1 (en) 2002-12-31
AR012977A1 (es) 2000-11-22
IS2435B (is) 2008-10-15
EP1219293A3 (en) 2003-05-28
SK17699A3 (en) 1999-07-12
HRP980317B1 (en) 2002-06-30
CO4940408A1 (es) 2000-07-24
PL331531A1 (en) 1999-07-19
EP1219293A2 (en) 2002-07-03
CN1138532C (zh) 2004-02-18
DE69807420T2 (de) 2003-05-08
IS4974A (is) 1999-02-11
AU8626298A (en) 1998-12-30
NO990594D0 (no) 1999-02-09
DZ2516A1 (fr) 2004-11-08
MEP44008A (en) 2011-02-10
NZ334149A (en) 2000-07-28
BR9805993B1 (pt) 2009-05-05
ATE222751T1 (de) 2002-09-15
ES2182351T3 (es) 2003-03-01
CZ46299A3 (cs) 1999-07-14
DK0920302T4 (da) 2006-10-09
EE9900055A (et) 1999-08-16
JP2000516965A (ja) 2000-12-19
ME00333B (me) 2011-02-10
ITMI971798A1 (it) 1999-01-28
DE69807420T3 (de) 2006-11-16
DK0920302T3 (da) 2002-12-23
EA199900201A1 (ru) 1999-06-24
DE69807420D1 (de) 2002-10-02
PL193721B1 (pl) 2007-03-30
GEP20012462B (en) 2001-06-25
ES2182351T5 (es) 2007-03-16
GB9712434D0 (en) 1997-08-13
IL128484A (en) 2004-09-27
SK284430B6 (sk) 2005-04-01
CN1229355A (zh) 1999-09-22
IT1293803B1 (it) 1999-03-10
BG63906B1 (bg) 2003-06-30
HRP980317A2 (en) 1999-04-30
UA70289C2 (uk) 2004-10-15
YU6999A (sh) 2000-03-21
AU729966B2 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
NO990594D0 (no) Farmas°ytisk aerosolsammensetning
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
ID24654A (id) Formulasi farmasi omeprazola
ID27415A (id) Komposisi farmaseutik
NO985539D0 (no) Farmas°ytiske blandinger
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
DE69936202D1 (de) Aerosol-zerstäuber
ID27150A (id) Sediaan levotiroksin bahan farmasi
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
BR1100755A (pt) composição farmacêutica
PT1041984E (pt) Composicao farmaceutica bebivel
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
MK1K Patent expired